Anavex Life Sciences Corp (AVXL)

[stealthways]

Also, another very possible scenery is that if Allergan is very serious about this class of drugs (which they appear to be) maybe they still are the suitor for AVXL, and want as many shots on goal as possible in the niche and with less competition .... much like AVXL going after 371 after they already had 273 .....If you assemble a team of experts in the niche why not spread the top talent over several drugs in the specialty... which is what avxl has done and Allergan may be also headed this way.... and still after avxl......and remember when you buy a company usually you have a crack at the top talent...look at what an avxl purchase could net Allergan in talent... it may be a no brainer...